A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Urologic Cancers Bookmark and Share

Urology and Urologic Cancers

At City of Hope, our physicians are leading experts in treating patients with all types of urologic cancers. Just as no two patients are alike, cancer requires a unique treatment plan tailored to each individual to attain the best possible outcomes.
 
As one of a select number of institutions to attain the elite designation of  Comprehensive Cancer Center from the National Cancer Institute, City of Hope is acknowledged as a leader in cancer research and treatment.  Patients at City of Hope have access to:
 
  • Researchers and physicians who are nationally recognized experts in developing novel methods for preventing, detecting and treating urologic cancers
  • A multidisciplinary team of specialists in medical oncology, surgery and recovery.
  • Innovative clinical trials on the latest promising treatments, many unavailable anywhere but City of Hope
 
We are actively developing tomorrow’s treatment protocols today for bladder, kidney, prostate and testicular cancers. City of Hope was one of the first cancer centers in the United States to perform robotic-assisted prostatectomy using the da Vinci® surgical system , and our surgeons have performed thousands of robotic urologic procedures.  The most significant benefits to patients are quicker recovery times and decreased blood loss compared to patients undergoing conventional “open incision” procedures.
 
City of Hope is home to one of California's largest prostate cancer program (according to data from the Office of Statewide Health Planning and Development, OSHPD) and maintains one of the country’s largest databases of prostate cancer outcomes. City of Hope also maintains a large database of bladder cancer outcomes to aid in developing new treatment protocols. We have also developed more precise tools to monitor cancer progression in men who have opted for active surveillance for prostate cancer. 
 
Other leading-edge treatments offered here include robotic-assisted laparoscopic cystectomy and bilateral pelvic lymph node dissection for muscle-invasive bladder cancer. In fact, we have performed the largest number of robotic-assisted radical cystectomy procedures worldwide. In addition, we perform a variety of procedures to treat kidney cancer/renal masses, including radical nephrectomy, nephron-sparing surgery (open, laparoscopic, or robotic-assisted), cryoablation and radio-frequency ablation (performed percutaneously or laparoscopically).
 
The staff of the Division of Urology and Urologic Oncology is recognized for its extensive expertise in minimally invasive surgery. We perform highly complex surgeries, such as retroperitoneal lymph node dissection for the treatment of testicular cancer. Because City of Hope offers the expertise of all cancer-related specialists in one location, patients receive greater continuity of care and more coordinated treatment planning. The Division of Urology also sees many patients who have urologic problems as a result of treatment of non-urologic cancers.

Our research is focused on the early diagnosis and prevention of prostate cancer, intraoperative imaging, identification of high-risk prostate cancer patients and quality-of-life issues involving prostate cancer treatment. At City of Hope, we are evaluating outcomes and patterns of cancer care for both prostate and bladder cancer and better defining the benefits of robotic-assisted surgery.
 

Urologic Cancers Team

Support this program

It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts 100 years ago. Their efforts − and those of our supporters today − have built the foundation for the care we provide and the research we conduct. It enables us to strive for new breakthroughs and better therapies − helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact us below.

Rick Leonard
Associate Vice President
Direct: 626-218-7218
Email: rleonard@coh.org

 
 

Urologic Cancers

Urology and Urologic Cancers

At City of Hope, our physicians are leading experts in treating patients with all types of urologic cancers. Just as no two patients are alike, cancer requires a unique treatment plan tailored to each individual to attain the best possible outcomes.
 
As one of a select number of institutions to attain the elite designation of  Comprehensive Cancer Center from the National Cancer Institute, City of Hope is acknowledged as a leader in cancer research and treatment.  Patients at City of Hope have access to:
 
  • Researchers and physicians who are nationally recognized experts in developing novel methods for preventing, detecting and treating urologic cancers
  • A multidisciplinary team of specialists in medical oncology, surgery and recovery.
  • Innovative clinical trials on the latest promising treatments, many unavailable anywhere but City of Hope
 
We are actively developing tomorrow’s treatment protocols today for bladder, kidney, prostate and testicular cancers. City of Hope was one of the first cancer centers in the United States to perform robotic-assisted prostatectomy using the da Vinci® surgical system , and our surgeons have performed thousands of robotic urologic procedures.  The most significant benefits to patients are quicker recovery times and decreased blood loss compared to patients undergoing conventional “open incision” procedures.
 
City of Hope is home to one of California's largest prostate cancer program (according to data from the Office of Statewide Health Planning and Development, OSHPD) and maintains one of the country’s largest databases of prostate cancer outcomes. City of Hope also maintains a large database of bladder cancer outcomes to aid in developing new treatment protocols. We have also developed more precise tools to monitor cancer progression in men who have opted for active surveillance for prostate cancer. 
 
Other leading-edge treatments offered here include robotic-assisted laparoscopic cystectomy and bilateral pelvic lymph node dissection for muscle-invasive bladder cancer. In fact, we have performed the largest number of robotic-assisted radical cystectomy procedures worldwide. In addition, we perform a variety of procedures to treat kidney cancer/renal masses, including radical nephrectomy, nephron-sparing surgery (open, laparoscopic, or robotic-assisted), cryoablation and radio-frequency ablation (performed percutaneously or laparoscopically).
 
The staff of the Division of Urology and Urologic Oncology is recognized for its extensive expertise in minimally invasive surgery. We perform highly complex surgeries, such as retroperitoneal lymph node dissection for the treatment of testicular cancer. Because City of Hope offers the expertise of all cancer-related specialists in one location, patients receive greater continuity of care and more coordinated treatment planning. The Division of Urology also sees many patients who have urologic problems as a result of treatment of non-urologic cancers.

Our research is focused on the early diagnosis and prevention of prostate cancer, intraoperative imaging, identification of high-risk prostate cancer patients and quality-of-life issues involving prostate cancer treatment. At City of Hope, we are evaluating outcomes and patterns of cancer care for both prostate and bladder cancer and better defining the benefits of robotic-assisted surgery.
 

Urologic Cancers Team

Urologic Cancers Team

Support This Program

Support this program

It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts 100 years ago. Their efforts − and those of our supporters today − have built the foundation for the care we provide and the research we conduct. It enables us to strive for new breakthroughs and better therapies − helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact us below.

Rick Leonard
Associate Vice President
Direct: 626-218-7218
Email: rleonard@coh.org

 
 
Quick Links
Meet our doctors: Urologist Jonathan Yamzon on curingtesticular cancer

Meet our doctors: Urologist Jonathan Yamzon on curing testicular cancer

Testicular cancer is the most common form of cancer in men 15 to 34 years old. Yet it accounts for only 1 percent of all cancers in men in the United States. According to the American Cancer Society, ...

May 31, 2014

 
Urologic cancers: Dispatches from research’s frontlines

Urologic cancers: Dispatches from research’s front lines

Urologic cancers, including prostate cancer, kidney cancer and bladder cancer, are diagnosed in more than 381,000 Americans each year, and almost 60,000 people die from the diseases. City of Hope’s ph...

March 28, 2014

 
Meet our doctors: Surgeon Jennifer Linehan on prostatecancer

Meet our doctors: Surgeon Jennifer Linehan on prostate cancer

Prostate cancer is one of the most common types of cancer affecting men, with one in six American men receiving the diagnosis in their lifetime. In most cases, the disease grows slowly and causes no p...

December 7, 2013

 
City of Hope surgeon Laura Crocitto, M.D., talks aboutvitamin E and prostate cancer

City of Hope surgeon Laura Crocitto, M.D., talks about vitamin E and prostate cancer

You may have heard talk on the news about a link between vitamins and prostate cancer. A new study in the Journal of the American Medical Association  reveals that men should be more aware of the...

October 17, 2011

 
Why should men care about prostate cancer?

Why should men care about prostate cancer?

Timothy Wilson, M.D., Director, Prostate Cancer Program and Chief of the Division of Urology and Urologic Oncology Cancers at City of Hope, discusses why men should pay attention to prostate canc...

October 10, 2011

 
With Cancer, Expertise Matters

 
Cancer patients need to have confidence in their treatment plans by exploring all possible options. Often that means they should get a second opinion. For these four patients, getting a second opinion from experts at City of Hope was life-saving.
Urology and Urologic Oncology Research

City of Hopes's Division of Urology strives to improve quality of care through innovative research that helps expand our understanding of urologic cancers. This brochure provides the key areas of research and studies our division is focusing on.
 
 
The Division of Urology and Urologic Oncology at City of Hope offers a Fellowship in Urologic Oncology with special emphasis on minimally invasive and robotic techniques.
Clinical Trials
Our aggressive pursuit to discover better ways to help patients now – not years from now – places us among the leaders worldwide in the administration of clinical trials.
 


NEWS & UPDATES
  • When Keith McKinny, 29, was first diagnosed with lymphoma and leukemia in 2010, the first person he thought of was former boyfriend Jason Mullins. The two hadn’t been in contact with each other for some time, but McKinny couldn’t think of anyone else with whom he wanted to be during that difficult period....
  • Yesenia Portillo’s search for a bone marrow donor started close to home. Her brother, sister and seven cousins all underwent testing, but none of them were a close enough match to donate the bone marrow stem cells she desperately needed for her transplant. Yesenia, now 16, had always been healthy and active. Bu...
  • Some of City of Hope’s most high-impact achievements have arisen from City of Hope’s globally recognized bone marrow transplant (BMT) program. The annual Karl G. Blume – Gerhard Schmidt Memorial Lecture in Transplantation Biology & Medicine — commemorating two of the most influential and revered...
  • Guido Marcucci, M.D., wants to put himself out of business. A respected clinician and esteemed basic and translational scientist, Marcucci joins City of Hope as co-director of the Gehr Family Center for Leukemia Research within the Hematologic Malignancies and Stem Cell Transplantation Institute. In this positi...
  • To say that myelofibrosis patients need more treatment options would be an understatement. The severely low platelet counts, known as thrombocytopenia, that are one of the hallmark symptoms of the disease can lead to chronic fatigue and weakness that not only damage quality of life but, ultimately, shorten life...
  • Patients with metastatic colorectal cancer often stop responding to the primary drugs used against the disease, leaving them with few options and little hope. Determined to increase those options, doctors and researchers at City of Hope are conducting two clinical trials that could lead to new treatments for pe...
  • Investigators working at City of Hope are making many significant inroads against many forms of cancer. To do that, they have to take a variety of approaches. Molecular oncology researchers focus on abnormal cancer-associated activity in a cell’s nucleus. One especially prominent factor in many breast and ovari...
  • In light of the new breast cancer screening guidelines, which call for women to have mammograms every other year from age 50 to 74, it’s more important than ever for women to understand their individual risk. On Monday, the U.S. Preventive Services Task force released new breast cancer screening guideline...
  • Cancer patients need, and deserve, more than medical care. They and their families need high-quality supportive care – that is, care that addresses their physical, emotional and spiritual well-being. Health care professionals increasingly understand this, but starting such programs from scratch isn’t easy...
  • Each year, City of Hope patients given another chance at life gather to pose for a picture like this one. Going on its 39th year, the celebration of patients free of blood cancers thanks to bone marrow or stem cell transplants has grown such that a photographer has to scale a cherry picker just to […]
  • Cancer patients who are participating in early-stage clinical trials need extra emotional and physical support due to their additional stress and often unique symptoms. Now an effort by researchers at City of Hope to create a model for such support has received a $6.8 million grant from the National Cancer Inst...
  • The need for improvements in treating malignant brain tumors has never been greater. Survival for many patients with these tumors are sometimes measured in just months. One reason that therapeutic options are limited is that traditional surgery is deemed too risky for many brain tumors, especially for those in ...
  • “Honestly, there’s nothing special about my story,” protested Daniel Samson, as he bounced Layla, his 3 1/2-year-old daughter, on his lap and put on a video for her to watch. “I just want to tell it for my own sake, and share it with other men who may be going through this chaos.” Samson spoke […]
  • As far back as he can remember, Jonathan Yamzon, M.D., wanted to be a doctor. “I knew it from the get-go,” he said, matter-of-factly. “I always envisioned it as the ideal; the supreme thing one could do with one’s life.” The youngest of six children, Yamzon was barely a toddler when his family moved to [&...
  • There’s never a “good” time for cancer to strike. With testicular cancer, the timing can seem particularly unfair. This disease targets young adults in the prime of life; otherwise healthy people unaccustomed to any serious illness, let alone cancer. And suddenly … “I can only imagine what they must...